Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Harte-Hanks announces suspension of trading, commences delisting procedures » 17:42
07/10/20
07/10
17:42
07/10/20
17:42
HHS

Harte-Hanks

$2.75 /

-0.22 (-7.41%)

Harte Hanks announced the…

Harte Hanks announced the company was notified by the NYSE on July 9 that the NYSE had determined to commence proceedings to delist the company's common stock as a result of the company's failure to comply with the continued listing standard to maintain either (i) at least $50M in stockholders' equity or (ii) at least $50M in total market capitalization on a 30-trading day average basis. While the company has the ability to appeal the decision by the NYSE, Harte Hanks' board has determined that it is in the best interest of the company and its shareholders to immediately begin trading on the OTCQX Best Market. The company will remain subject to the public reporting requirements of the SEC following the transfer to the OTCQX and expects the common stock will trade under the symbol "HRTE". The transition to the over-the-counter markets will not affect the company's business operations.

ShowHide Related Items >><<
HHS Harte-Hanks
$2.75 /

-0.22 (-7.41%)

Hot Stocks
Harte Hanks trading halted, news pending  17:22
07/10/20
07/10
17:22
07/10/20
17:22
HHS

Harte-Hanks

$2.75 /

-0.22 (-7.41%)

 
ShowHide Related Items >><<
HHS Harte-Hanks
$2.75 /

-0.22 (-7.41%)

Over a month ago
Hot Stocks
Harte-Hanks selected by Flagship Biosciences to provide marketing solutions » 16:14
06/03/20
06/03
16:14
06/03/20
16:14
HHS

Harte-Hanks

$2.77 /

+0.335 (+13.79%)

Harte Hanks announced…

Harte Hanks announced that it has been selected by Flagship Biosciences to provide strategic marketing solutions in developing a new customer acquisition program. Harte Hanks will be developing a targeted, multi-channel campaign including email, digital advertising and content creation to help Flagship Biosciences engage priority audiences, nurture leads and connect with potential clients.

Over a quarter ago
Hot Stocks
Harte-Hanks appoints Andrew Benett as CEO, Lauri Kearnes as CFO » 08:16
11/18/19
11/18
08:16
11/18/19
08:16
HHS

Harte-Hanks

$2.79 /

+ (+0.00%)

Harte Hanks announced a…

Harte Hanks announced a transformation of its senior leadership team, signaling the final stage of its restructuring efforts and a renewed focus on driving growth and deepening customer engagements. Effective immediately: Andrew Benett was appointed as Executive Chairman and CEO. Most recently, Andrew served as the Global CCO at Bloomberg Media Group. Brian Linscott was appointed COO. Most recently, he served as Partner at BR Advisors. Lauri Kearnes was promoted to CFO replacing Mark Del Priore, who will be leaving the Company. Kearnes previously was the Vice President of Finance and Corporate Controller at Harte Hanks. Evan Behrens was named Lead Independent Director. Andrew Harrison stepped down as president, but will remain with the Company, and report to Andrew Benett in an executive advisory role.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.